Expression of IL-12 in CNS and lymphoid organs of mice with experimental allergic encephalitis

被引:84
作者
Bright, JJ [1 ]
Musuro, BF [1 ]
Du, C [1 ]
Sriram, S [1 ]
机构
[1] 1222 Vanderbilt Stallworth Rehabil Hosp, Multiple Sclerosis Res Lab, Nashville, TN 37212 USA
关键词
interleukin-12; experimental allergic encephalitis; multiple sclerosis; CNS demyelination;
D O I
10.1016/S0165-5728(97)00184-7
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
EAE is a Th1 cell-mediated inflammatory autoimmune demyelinating disease of the central nervous system. IL-12 is a 70 kd heterodimeric cytokine, capable of regulating a wide range of immune functions. In view of its crucial role in the development of Th1 immune responses, we studied the expression of IL-12 p40 in the CNS and lymphoid organs of mice with EAE. RT-PCR analysis showed an increase in the expression of IL-12 p40 in brain and spinal cord during the acute paralytic phase of EAE and that decreased upon clinical recovery. The expression of p40 mRNA was also increased in spleen, lymph node and liver along with an elevated levels of circulating serum IL-12 during the height of disease. In vivo administration of rIL-12 increased the proliferative response and IFN-gamma production of MBP sensitized T cells and that was decreased following treatment with anti-IL-12 antibody. The expression of IL-12 in the target and lymphoid organs of animals with EAE, the induction of a Th1 type immune response following immunization with neuronal antigens and the inhibition of clinical disease upon treatment with anti-IL-12 antibody, suggest the crucial role of IL-12 in the pathogenesis of EAE. (C) 1998 Elsevier Science B.V.
引用
收藏
页码:22 / 30
页数:9
相关论文
共 45 条
  • [21] MANNIE MD, 1987, J IMMUNOL, V138, P4229
  • [22] IMMUNOLOGICAL ASPECTS OF DEMYELINATING DISEASES
    MARTIN, R
    MCFARLAND, HF
    MCFARLIN, DE
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1992, 10 : 153 - 187
  • [23] Maruo S, 1996, J IMMUNOL, V156, P1748
  • [24] MULTIPLE-SCLEROSIS .1.
    MCFARLIN, DE
    MCFARLAND, HF
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1982, 307 (19) : 1183 - 1188
  • [25] MCKNIGHT AJ, 1994, J IMMUNOL, V152, P2172
  • [26] INFLAMMATORY LEUKOCYTES AND CYTOKINES IN THE PEPTIDE-INDUCED DISEASE OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS IN SJL AND B10.PL MICE
    MERRILL, JE
    KONO, DH
    CLAYTON, J
    ANDO, DG
    HINTON, DR
    HOFMAN, FM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (02) : 574 - 578
  • [27] ANTIBODIES TO INTERLEUKIN-12 ABROGATE ESTABLISHED EXPERIMENTAL COLITIS IN MICE
    NEURATH, MF
    FUSS, I
    KELSALL, BL
    STUBER, E
    STROBER, W
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (05) : 1281 - 1290
  • [28] THE IMMUNOLOGY OF MULTIPLE-SCLEROSIS AND ITS ANIMAL-MODEL, EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS
    OWENS, T
    SRIRAM, S
    [J]. NEUROLOGIC CLINICS, 1995, 13 (01) : 51 - 73
  • [29] PEARLMAN E, 1995, J IMMUNOL, V154, P4658
  • [30] LONG-TERM TREATMENT OF CHRONIC RELAPSING EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS BY TRANSFORMING GROWTH-FACTOR-BETA-2
    RACKE, MK
    SRIRAM, S
    CARLINO, J
    CANNELLA, B
    RAINE, CS
    MCFARLIN, DE
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 1993, 46 (1-2) : 175 - 184